Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-04-09

Clinical Trial Update: Study of Varencline Effects on Cigarette Smoking Reward and Craving During a Model of Brief Quit Attempt [Phase 1, Phase 2]

View source ↗

Summary

The Phase 1/2 trial investigating varenicline effects on cigarette smoking reward and craving during a brief quit attempt has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varenicline (varenicline)

Snippet

Sponsor: NYU Langone Health | Conditions: Nicotine Dependence | Phase 1, Phase 2 | Status: WITHDRAWN